Stay updated on Intratumoral SD-101 + Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Intratumoral SD-101 + Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intratumoral SD-101 + Pembrolizumab Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Layout and navigation appear adjusted between the two screenshots, while core study sections such as endpoints, eligibility criteria, and enrollment show no visible changes.
    Difference
    0.0%
    Check dated 2026-03-16T03:27:41.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3. No other visible changes to content or layout on the Study Details page.
    Difference
    0.1%
    Check dated 2026-03-09T00:30:16.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Added a label 'Revision: v3.4.2' to the page. The previous 'Revision: v3.4.1' label is no longer displayed.
    Difference
    0.0%
    Check dated 2026-02-15T15:07:53.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added in the page footer, replacing v3.4.0. This is a minor UI update and does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-08T09:29:38.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    A glossary toggle was added; QA-related labels and capitalization were updated (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and the footer now shows 'Revision: v3.4.0'.
    Difference
    0.1%
    Check dated 2026-01-24T04:58:55.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page metadata shows a revision update from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-17T03:30:12.000Z thumbnail image

Stay in the know with updates to Intratumoral SD-101 + Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intratumoral SD-101 + Pembrolizumab Clinical Trial page.